Tendencias en el cáncer cerebral.

Cancer mortality in Europe, 1990-92.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·1995

Trends of skin cancer in the Canton of Vaud, 1976-92.

British journal of cancer·1995

Pancreatitis and the risk of pancreatic cancer.

Pancreas·1995

Influence of some covariates on the reproducibility of an Italian semi-quantitative food frequency questionnaire.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·1995

Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

Journal of epidemiology and community health·1995

HIV transmission and Kaposi's sarcoma among European women.

AIDS (London, England)·1995

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Disrupting Bacterial Quorum Sensing: A Review of Protein Families and Natural Inhibitors for Combating Resistance.

Current topics in medicinal chemistry·2026

Design, Optimization and Physicochemical Characterization of Pectin-Based Nanoparticles for In Vitro Anticancer Evaluation Against HCT116 Colon Cancer Cells.

Current pharmaceutical design·2026

Integrative bioinformatics and in vivo validation suggest a potential role of <i>Cbr4</i> in alcohol use disorder through modulation of lipid metabolism and treg cell function in the central amygdala.

Frontiers in genetics·2026

Research progress of cuproptosis, ferroptosis, apoptosis, and autophagy in knee osteoarthritis.

Frontiers in cell and developmental biology·2026

Integrating multi-omics and machine learning to uncover CCL20 as a potential regulator of the immunosuppressive microenvironment in lung adenocarcinoma.

Frontiers in immunology·2026

Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing.

Frontiers in immunology·2026

Videos de Experimentos Relacionados

Tendencias en el cáncer cerebral.

Videos de Conceptos Relacionados

Cancer mortality in Europe, 1990-92.

Trends of skin cancer in the Canton of Vaud, 1976-92.

Pancreatitis and the risk of pancreatic cancer.

Influence of some covariates on the reproducibility of an Italian semi-quantitative food frequency questionnaire.

Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

HIV transmission and Kaposi's sarcoma among European women.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Disrupting Bacterial Quorum Sensing: A Review of Protein Families and Natural Inhibitors for Combating Resistance.

Design, Optimization and Physicochemical Characterization of Pectin-Based Nanoparticles for In Vitro Anticancer Evaluation Against HCT116 Colon Cancer Cells.

Integrative bioinformatics and in vivo validation suggest a potential role of <i>Cbr4</i> in alcohol use disorder through modulation of lipid metabolism and treg cell function in the central amygdala.

Research progress of cuproptosis, ferroptosis, apoptosis, and autophagy in knee osteoarthritis.

Integrating multi-omics and machine learning to uncover CCL20 as a potential regulator of the immunosuppressive microenvironment in lung adenocarcinoma.

Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing.

Videos de Experimentos Relacionados

Tendencias en el cáncer cerebral.

Videos de Conceptos Relacionados

Artículos Relacionados